Alexander R. Judkins
Affiliations: | Neuropathology | University of Pennsylvania, Philadelphia, PA, United States |
Website:
http://www.chop.edu/doctors/judkins-alexander-r.htmlGoogle:
"Alexander Judkins"Bio:
MD
Children's Hospital of Philadelphia
Department of Pathology
34th and Civic Center Blvd.
Main Bldg., Room 5203
Philadelphia, PA 19104
United States
Cross-listing: Neurotree
Parents
Sign in to add mentor| Jeffrey A. Golden | post-doc | Children’s Hospital of Philadelphia / University of Pennsylvania | ||
| Nicholas K. Gonatas | post-doc | Penn | ||
| (Late 1990's) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Xue Y, Zhu X, Meehan B, et al. (2020) SMARCB1 loss induces druggable cyclin D1 deficiency via upregulation of MIR17HG in atypical teratoid rhabdoid tumors. The Journal of Pathology |
| Pratt D, Quezado M, Abdullaev Z, et al. (2020) Diffuse intrinsic pontine glioma-like tumor with EZHIP expression and molecular features of PFA ependymoma. Acta Neuropathologica Communications. 8: 37 |
| Hoffman LM, Richardson EA, Ho B, et al. (2020) Advancing biology based therapeutic approaches for atypical teratoid rhabdoid tumors. Neuro-Oncology |
| Reddy AT, Strother DR, Judkins AR, et al. (2020) Efficacy of High-Dose Chemotherapy and Three-Dimensional Conformal Radiation for Atypical Teratoid/Rhabdoid Tumor: A Report From the Children's Oncology Group Trial ACNS0333. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1901776 |
| Panwalkar P, Pratt D, Chung C, et al. (2020) SWI/SNF complex heterogeneity relates with polyphenotypic differentiation, prognosis and immune response in rhabdoid tumors. Neuro-Oncology |
| Li BK, Burger P, Judkins AR, et al. (2020) PATH-24. MOLECULAR CLASSIFICATION OF HIGH RISK INFANT EMBRYONAL BRAIN TUMORS ENROLLED IN THE ACNS0334 TRIAL: A REPORT FROM THE CHILDREN’S ONCOLOGY GROUP Neuro-Oncology. 22: iii429-iii429 |
| Tamrazi B, Venneti S, Margol A, et al. (2019) Pediatric Atypical Teratoid/Rhabdoid Tumors of the Brain: Identification of Metabolic Subgroups Using In Vivo H-MR Spectroscopy. Ajnr. American Journal of Neuroradiology |
| Toll SA, Tran HN, Cotter J, et al. (2019) Sustained response of three pediatric BRAF mutated high-grade gliomas to combined BRAF and MEK inhibitor therapy. Oncotarget. 10: 551-557 |
| Xue Y, Meehan B, Macdonald E, et al. (2019) CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary. Nature Communications. 10: 558 |
| Xue Y, Meehan B, Fu Z, et al. (2019) SMARCA4 loss is synthetic lethal with CDK4/6 inhibition in non-small cell lung cancer. Nature Communications. 10: 557 |